BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216-30. [PMID: 15273544 DOI: 10.1097/01.sla.0000132986.75257.19] [Cited by in Crossref: 137] [Cited by in F6Publishing: 104] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Di Nicuolo G, van de Kerkhove MP, Hoekstra R, Beld MG, Amoroso P, Battisti S, Starace M, di Florio E, Scuderi V, Scala S, Bracco A, Mancini A, Chamuleau RA, Calise F. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Xenotransplantation 2005;12:286-92. [PMID: 15943777 DOI: 10.1111/j.1399-3089.2005.00226.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
2 O'grady J. Personal view: current role of artificial liver support devices. Aliment Pharmacol Ther 2006;23:1549-57. [DOI: 10.1111/j.1365-2036.2006.02931.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Arisaka Y, Yui N. Engineering molecularly mobile polyrotaxane surfaces with heparin‐binding EGF‐like growth factors for improving hepatocyte functions. J Biomed Mater Res 2019;107:1080-5. [DOI: 10.1002/jbm.a.36646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
4 Davidson AJ, Ellis MJ, Chaudhuri JB. A theoretical method to improve and optimize the design of bioartificial livers. Biotechnol Bioeng 2010;106:980-8. [PMID: 20506230 DOI: 10.1002/bit.22765] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
5 Nibourg GA, Chamuleau RA, van Gulik TM, Hoekstra R. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review. Expert Opinion on Biological Therapy 2012;12:905-21. [DOI: 10.1517/14712598.2012.685714] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
6 Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation. 2009;88:1041-1049. [PMID: 19898198 DOI: 10.1097/tp.0b013e3181ba0555] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
7 Carraro A, Flaibani M, Cillo U, Michelotto L, Magrofuoco E, Buggio M, Abatangelo G, Cortivo R, Herrera MB, Tetta C, Elvassore N, Zavan B. A combining method to enhance the in vitro differentiation of hepatic precursor cells. Tissue Eng Part C Methods 2010;16:1543-51. [PMID: 20504066 DOI: 10.1089/ten.TEC.2009.0795] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
8 van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634-1643. [PMID: 18395843 DOI: 10.1002/hep.22236] [Cited by in Crossref: 366] [Cited by in F6Publishing: 334] [Article Influence: 28.2] [Reference Citation Analysis]
9 Ferenci P, Kramer L. MARS and the failing liver-Any help from the outer space? Hepatology 2007;46:1682-4. [PMID: 18046718 DOI: 10.1002/hep.22031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
10 Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial. 2006;10:168-174. [PMID: 16684219 DOI: 10.1111/j.1744-9987.2006.00359.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
11 Crespo I, Miguel BS, Laliena A, Alvarez M, Culebras JM, González-Gallego J, Tuñón MJ. Melatonin prevents the decreased activity of antioxidant enzymes and activates nuclear erythroid 2-related factor 2 signaling in an animal model of fulminant hepatic failure of viral origin. J Pineal Res 2010;49:193-200. [PMID: 20609075 DOI: 10.1111/j.1600-079X.2010.00787.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
12 Bektas M, Idilman R, Soykan I, Soydan E, Arat M, Cinar K, Coban S, Tuzun A, Bozkaya H, Ormeci N, Ozden A. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. J Clin Gastroenterol. 2008;42:517-521. [PMID: 18344887 DOI: 10.1097/mcg.0b013e31815878ff] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
13 Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27-36. [PMID: 22836216 DOI: 10.1097/sla.0b013e31825d5d47] [Cited by in Crossref: 176] [Cited by in F6Publishing: 74] [Article Influence: 22.0] [Reference Citation Analysis]
14 Diekmann S, Bader A, Schmitmeier S. Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 2006;50:163-79. [PMID: 19003077 DOI: 10.1007/s10616-006-6336-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
15 Mazariegos G, Chen Y, Squires R. Biological and artificial liver support system in children: A new perspective*: . Pediatric Critical Care Medicine 2005;6:616-7. [DOI: 10.1097/01.pcc.0000170609.49863.03] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
16 Deschamps JY, Roux FA, Saï P, Gouin E. History of xenotransplantation. Xenotransplantation 2005;12:91-109. [PMID: 15693840 DOI: 10.1111/j.1399-3089.2004.00199.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
17 Poyck PP, Pless G, Hoekstra R, Roth S, Van Wijk AC, Schwartländer R, Van Gulik TM, Sauer IM, Chamuleau RA. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Int J Artif Organs 2007;30:183-91. [PMID: 17417756 DOI: 10.1177/039139880703000302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Underhill GH, Khetani SR. Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies. Cell Mol Gastroenterol Hepatol 2018;5:426-439.e1. [PMID: 29675458 DOI: 10.1016/j.jcmgh.2017.11.012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 18.5] [Reference Citation Analysis]
19 Park IS. Synergistic effect of three-dimensional coculture and photobiomodulation therapy on vascularized liver spheroid formation by stem cells. J Cell Physiol 2021;236:5865-74. [PMID: 33432611 DOI: 10.1002/jcp.30270] [Reference Citation Analysis]
20 Fukuda J, Okamura K, Ishihara K, Mizumoto H, Nakazawa K, Ijima H, Kajiwara T, Funatsu K. Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplant 2005;14:819-27. [DOI: 10.3727/000000005783982503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
21 Coward SM, Legallais C, David B, Thomas M, Foo Y, Mavri-Damelin D, Hodgson HJ, Selden C. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs. 2009;33:1117-1126. [PMID: 20078562 DOI: 10.1111/j.1525-1594.2009.00821.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
22 De Wolf AM. Preoperative optimization of patients with liver disease. Current Opinion in Anaesthesiology 2005;18:325-31. [DOI: 10.1097/01.aco.0000169242.03754.cc] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
23 Meng F, Assiri A, Dhar D, Broering D. Whole liver engineering: A promising approach to develop functional liver surrogates. Liver Int 2017;37:1759-72. [DOI: 10.1111/liv.13444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Poyck PP, Hoekstra R, van Wijk AC, Attanasio C, Calise F, Chamuleau RA, van Gulik TM. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. Liver Transpl. 2007;13:589-598. [PMID: 17394165 DOI: 10.1002/lt.21090] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
25 Andria B, Bracco A, Cirino G, Chamuleau RA. Liver Cell Culture Devices. Cell Med 2010;1:55-70. [PMID: 26998397 DOI: 10.3727/215517910X519274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Liu H, You S, Rong Y, Wu Y, Zhu B, Wan Z, Liu W, Mao P, Xin S. Newly established human liver cell line: a potential cell source for the bioartificial liver in the future. Hum Cell. 2013;26:155-161. [PMID: 23797278 DOI: 10.1007/s13577-013-0068-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012;11:243-9. [PMID: 22672816 DOI: 10.1016/s1499-3872(12)60155-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Todo S. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell Transplant 2008;17:1083-94. [DOI: 10.3727/096368908786991542] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
29 Davidson AJ, Ellis MJ, Chaudhuri JB. A theoretical approach to zonation in a bioartificial liver. Biotechnol Bioeng 2012;109:234-43. [PMID: 21809328 DOI: 10.1002/bit.23279] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
30 Poyck PP, Hoekstra R, van Wijk AC, ten Bloemendaal L, Chamuleau RA, van Gulik TM. Mild Hypothermic Preservation for Transport Purposes of the AMC Bioartificial Liver Charged with Porcine Hepatocytes: . Transplantation 2005;80:1153-60. [DOI: 10.1097/01.tp.0000183958.79272.cb] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 van de Kerkhove MP, Poyck PP, Deurholt T, Hoekstra R, Chamuleau RA, van Gulik TM. Liver support therapy: an overview of the AMC-bioartificial liver research. Dig Surg. 2005;22:254-264. [PMID: 16174982 DOI: 10.1159/000088055] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
32 Ekser B, Long C, Echeverri GJ, Hara H, Ezzelarab M, Lin CC, de Vera ME, Wagner R, Klein E, Wolf RF, Ayares D, Cooper DK, Gridelli B. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant. 2010;10:273-285. [PMID: 20041862 DOI: 10.1111/j.1600-6143.2009.02945.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
33 Chamuleau RA, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis. 2005;20:327-335. [PMID: 16382343 DOI: 10.1007/s11011-005-7914-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
34 Mareels G, Poyck PP, Eloot S, Chamuleau RA, Verdonck PR. Three-dimensional numerical modeling and computational fluid dynamics simulations to analyze and improve oxygen availability in the AMC bioartificial liver. Ann Biomed Eng 2006;34:1729-44. [PMID: 17031599 DOI: 10.1007/s10439-006-9169-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
35 Sarin SK, Choudhury A. Acute-on-chronic Liver Failure. Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0535-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
36 Fujii Y, Higashi K, Mizumoto H, Kamihira M, Kajiwara T. A bioartificial liver device based on three-dimensional culture of genetically engineered hepatoma cells using hollow fibers. Cytotechnology 2020;72:227-37. [PMID: 32016712 DOI: 10.1007/s10616-020-00372-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Chen Z, Ding YT. Functional evaluation of a new bioartificial liver system in vitro and in vitro. World J Gastroenterol. 2006;12:1312-1316. [PMID: 16534893 DOI: 10.3748/wjg.v12.i8.1857] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
38 Gerlach JC, Zeilinger K, Patzer Ii JF. Bioartificial liver systems: why, what, whither? Regenerative Medicine 2008;3:575-95. [DOI: 10.2217/17460751.3.4.575] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
39 Giri S, Acikgöz A, Pathak P, Gutschker S, Kürsten A, Nieber K, Bader A. Three dimensional cultures of rat liver cells using a natural self-assembling nanoscaffold in a clinically relevant bioreactor for bioartificial liver construction. J Cell Physiol 2012;227:313-27. [PMID: 21437901 DOI: 10.1002/jcp.22738] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
40 Nussler AK, Zeilinger K, Schyschka L, Ehnert S, Gerlach JC, Yan X, Lee SM, Ilowski M, Thasler WE, Weiss TS. Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. J Mater Sci Mater Med 2011;22:1087-99. [PMID: 21461918 DOI: 10.1007/s10856-011-4306-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Kellum JA, Venkataraman R. Application of blood purification to non-renal organ failure. Int J Artif Organs 2005;28:445-9. [PMID: 15883958 DOI: 10.1177/039139880502800504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
42 Millis JM, Losanoff JE. Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2005;2:398-405; quiz 434. [PMID: 16265430 DOI: 10.1038/ncpgasthep0254] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
43 Sauer IM, Baurmeister U. Cell-Free Artificial Liver Support. Therapher Dial 2006;10:105-7. [DOI: 10.1111/j.1744-9987.2006.00350.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Liu W, Zhang M, Zhou M, Gu C, Ye Z, Xiao Y, Zhou Y, Lang M, Tan WS. Fabrication and evaluation of modified poly(ethylene terephthalate) microfibrous scaffolds for hepatocyte growth and functionality maintenance. Mater Sci Eng C Mater Biol Appl 2020;109:110523. [PMID: 32228959 DOI: 10.1016/j.msec.2019.110523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Ouattara DA, Prot JM, Bunescu A, Dumas ME, Elena-Herrmann B, Leclerc E, Brochot C. Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells. Mol Biosyst 2012;8:1908-20. [PMID: 22618574 DOI: 10.1039/c2mb25049g] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
46 Vasanthan KS, Subramaniam A, Krishnan UM, Sethuraman S. Influence of 3D porous galactose containing PVA/gelatin hydrogel scaffolds on three-dimensional spheroidal morphology of hepatocytes. J Mater Sci Mater Med 2015;26:5345. [PMID: 25578699 DOI: 10.1007/s10856-014-5345-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
47 Wijdicks EF, Hocker SE. Neurologic complications of liver transplantation. Handb Clin Neurol 2014;121:1257-66. [PMID: 24365417 DOI: 10.1016/B978-0-7020-4088-7.00085-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
48 Bilgic Y, Akbulut S, Cengiz A, Sarici A, Cagin Y, Harputluoglu M. Therapeutic Effects of Plasmapheresis on Acute Exacerbations of Chronic Hepatitis B Infection. Cureus 2021;13:e12779. [PMID: 33628651 DOI: 10.7759/cureus.12779] [Reference Citation Analysis]
49 Bikhchandani J, Metcalfe M, Illouz S, Puls F, Dennison A. Extracorporeal liver perfusion system for artificial liver support across a membrane. J Surg Res 2011;171:e139-47. [PMID: 21920550 DOI: 10.1016/j.jss.2011.07.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Zhao C, Li Y, Peng G, Lei X, Zhang G, Gao Y. Decellularized liver matrix-modified chitosan fibrous scaffold as a substrate for C3A hepatocyte culture. J Biomater Sci Polym Ed 2020;31:1041-56. [PMID: 32162599 DOI: 10.1080/09205063.2020.1738690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Zheng Z, Li X, Li Z, Ma X. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression. Exp Ther Med. 2013;6:929-936. [PMID: 24137292 DOI: 10.3892/etm.2013.1241] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
52 Chen G, Palmer AF. Mixtures of hemoglobin-based oxygen carriers and perfluorocarbons exhibit a synergistic effect in oxygenating hepatic hollow fiber bioreactors. Biotechnol Bioeng 2010;105:534-42. [DOI: 10.1002/bit.22571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
53 van de Kerkhove M, Germans MR, Deurholt T, Hoekstra R, Joziasse DH, van Wijk AC, van Gulik TM, Chamuleau RA, Roos A. Evidence for Galα(1–3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems. Journal of Hepatology 2005;42:541-7. [DOI: 10.1016/j.jhep.2004.11.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
54 Carraro A, Buggio M, Gardin C, Tedeschi U, Ferroni L, Zavan PB. Mesenchymal Stem Cells Increase Neo-Angiogenesis and Albumin Production in a Liver Tissue-Engineered Engraftment. Int J Mol Sci. 2016;17:374. [PMID: 26985891 DOI: 10.3390/ijms17030374] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
55 Sgroi A, Serre-Beinier V, Morel P, Bühler L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation. 2009;87:457-466. [PMID: 19307780 DOI: 10.1097/tp.0b013e3181963ad3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
56 Lee CW, Chen YF, Wu HH, Lee OK. Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases. Gastroenterology. 2018;154:46-56. [PMID: 29107021 DOI: 10.1053/j.gastro.2017.09.049] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
57 Chen C, Jochems PGM, Salz L, Schneeberger K, Penning LC, van de Graaf SFJ, Beuers U, Clevers H, Geijsen N, Masereeuw R, Spee B. Bioengineered bile ducts recapitulate key cholangiocyte functions. Biofabrication 2018;10:034103. [PMID: 29848792 DOI: 10.1088/1758-5090/aac8fd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
58 Li ZG, Liu GB, Pan MX, Wu QS, Ge M, Du J, Wang Y, Gao Y. Knockdown of porcine endogenous retroviruses by RNA interference in Chinese experimental miniature pig fibroblasts. Transplant Proc 2013;45:748-55. [PMID: 23498816 DOI: 10.1016/j.transproceed.2012.03.068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
59 van de Kerkhove MP, Poyck PP, van Wijk AC, Galavotti D, Hoekstra R, van Gulik TM, Chamuleau RA. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 2005;28:617-30. [PMID: 16015572 DOI: 10.1177/039139880502800611] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
60 Sosef MN, De Bondt RB, Bosma A, De Bruijn C, van Gulik TM. The fate of autologous hepatocytes transplanted into spleen, pancreas, mesentery, stomach, and small bowel wall in pigs. HPB (Oxford) 2007;9:216-8. [PMID: 18333225 DOI: 10.1080/13651820701329233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Dvir-Ginzberg M, Elkayam T, Cohen S. Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. FASEB J 2008;22:1440-9. [PMID: 18070820 DOI: 10.1096/fj.07-9277com] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
62 Kim D, Seo S, Cho H, Hong S, Lim D, Paek S. Continuous immunosensing of myoglobin in human serum as potential companion diagnostics technique. Biosensors and Bioelectronics 2014;62:234-41. [DOI: 10.1016/j.bios.2014.06.039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
63 Poyck PP, Hoekstra R, Chhatta A, Bloemendaal LT, van Wijk AC, Galavotti D, van Gulik TM, Chamuleau RA. Time-related analysis of metabolic liver functions, cellular morphology, and gene expression of hepatocytes cultured in the bioartificial liver of the Academic Medical Center in Amsterdam (AMC-BAL). Tissue Eng. 2007;13:1235-1246. [PMID: 17518723 DOI: 10.1089/ten.2006.0343] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
64 van Poll D, Sokmensuer C, Ahmad N, Tilles AW, Berthiaume F, Toner M, Yarmush ML. Elevated hepatocyte-specific functions in fetal rat hepatocytes co-cultured with adult rat hepatocytes. Tissue Eng 2006;12:2965-73. [PMID: 17518664 DOI: 10.1089/ten.2006.12.2965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
65 No da Y, Lee SA, Choi YY, Park D, Jang JY, Kim DS, Lee SH. Functional 3D human primary hepatocyte spheroids made by co-culturing hepatocytes from partial hepatectomy specimens and human adipose-derived stem cells. PLoS One 2012;7:e50723. [PMID: 23236387 DOI: 10.1371/journal.pone.0050723] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
66 Kosuge M, Takizawa H, Maehashi H, Matsuura T, Matsufuji S. A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor. Liver Int 2007;27. [DOI: 10.1111/j.1478-3231.2006.01410.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
67 Van De Kerkhove M, Hoekstra R, Van Nooijen FC, Spoelstra FOB, Doorschodt BM, Van Wijk ACWA, Poyck PPC, Chamuleau RAFM, Van Gulik TM. Subnormothermic Preservation Maintains Viability and Function in a Porcine Hepatocyte Culture Model Simulating Bioreactor Transport. Cell Transplant 2006;15:161-8. [DOI: 10.3727/000000006783982089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
68 Streetz KL. Bio-artificial liver devices – Tentative, but promising progress. Journal of Hepatology 2008;48:189-91. [DOI: 10.1016/j.jhep.2007.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
69 Schneider C, Aurich H, Wenkel R, Christ B. Propagation and functional characterization of serum-free cultured porcine hepatocytes for downstream applications. Cell Tissue Res 2006;323:433-42. [DOI: 10.1007/s00441-005-0089-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
70 Chen ML, Lee KD, Huang HC, Tsai YL, Wu YC, Kuo TM, Hu CP, Chang C. HNF-4α determines hepatic differentiation of human mesenchymal stem cells from bone marrow. World J Gastroenterol. 2010;16:5092-5103. [PMID: 20976847 DOI: 10.3748/wjg.v16.i40.5092] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
71 Jalan R. Acute liver failure: current management and future prospects. J Hepatol. 2005;42 Suppl:S115-S123. [PMID: 15777566 DOI: 10.1016/j.jhep.2004.11.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
72 Yang Q, Liu F, Pan XP, Lv G, Zhang A, Yu CB, Li L. Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission. Hepatol Int 2010;4:757-61. [PMID: 21286347 DOI: 10.1007/s12072-010-9210-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
73 Ring A, Gerlach J, Peters G, Pazin BJ, Minervini CF, Turner ME, Thompson RL, Triolo F, Gridelli B, Miki T. Hepatic Maturation of Human Fetal Hepatocytes in Four-Compartment Three-Dimensional Perfusion Culture. Tissue Engineering Part C: Methods 2010;16:835-45. [DOI: 10.1089/ten.tec.2009.0342] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
74 Palakkan AA, Hay DC, Pr AK, Tv K, Ross JA. Liver tissue engineering and cell sources: issues and challenges. Liver Int 2013;33:666-76. [DOI: 10.1111/liv.12134] [Cited by in Crossref: 80] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
75 Kantola T, Ilmakunnas M, Koivusalo A, Isoniemi H. Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland. Scand J Surg 2011;100:8-13. [DOI: 10.1177/145749691110000103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
76 Motobayashi M, Fukuyama T, Nakayama Y, Sano K, Noda S, Hidaka Y, Amano Y, Ikeda S, Koike K, Inaba Y. Successful treatment of fulminant Wilson's disease without liver transplantation. Pediatr Int. 2014;56:429-432. [PMID: 24894932 DOI: 10.1111/ped.12291] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
77 Meyer J, Balaphas A, Fontana P, Sadoul K, Morel P, Gonelle-gispert C, Bühler L. Platelets in liver regeneration. VOXS 2017;12:455-62. [DOI: 10.1111/voxs.12382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
78 Fukumitsu K, Ishii T, Yasuchika K, Amagai Y, Kawamura-Saito M, Kawamoto T, Kawase E, Suemori H, Nakatsuji N, Ikai I, Uemoto S. Establishment of a cell line derived from a mouse fetal liver that has the characteristic to promote the hepatic maturation of mouse embryonic stem cells by a coculture method. Tissue Eng Part A 2009;15:3847-56. [PMID: 19558317 DOI: 10.1089/ten.TEA.2009.0357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
79 Chistiakov DA. Liver regenerative medicine: advances and challenges. Cells Tissues Organs. 2012;196:291-312. [PMID: 22572238 DOI: 10.1159/000335697] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
80 Sharma R, Greenhough S, Medine CN, Hay DC. Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol. 2010;2010:236147. [PMID: 20169088 DOI: 10.1155/2010/236147] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
81 Subramanian RM, Kellum JA. Extracorporeal liver support: a continuing challenge. Crit Care 2007;11:106. [PMID: 17284306 DOI: 10.1186/cc5143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Maguire T, Novik E, Schloss R, Yarmush M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 2006;93:581-91. [PMID: 16345081 DOI: 10.1002/bit.20748] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 7.9] [Reference Citation Analysis]
83 Pham TS, Reda A, Ngan Nguyen TT, Ng SJ, Huan VT, Viet DC, Huy NT. Blood exchange transfusion in viral hepatitis in a small infant: a case report. Transfus Apher Sci 2020;59:102907. [PMID: 32883595 DOI: 10.1016/j.transci.2020.102907] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Ocak İ, Topaloğlu S, Acarli K. Posthepatectomy liver failure. Turk J Med Sci 2020;50:1491-503. [PMID: 32718126 DOI: 10.3906/sag-2006-31] [Reference Citation Analysis]
85 Ginai M, Elsby R, Hewitt CJ, Surry D, Fenner K, Coopman K. The use of bioreactors as in vitro models in pharmaceutical research. Drug Discov Today 2013;18:922-35. [PMID: 23748137 DOI: 10.1016/j.drudis.2013.05.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
86 Castaldo ET, Chari RS. Liver transplantation for acute hepatic failure. HPB (Oxford) 2006;8:29-34. [PMID: 18333235 DOI: 10.1080/13651820500465741] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
87 Detry O, Gaspar Y, Cheramy-Bien JP, Drion P, Meurisse M, Defraigne JO. A modified surgical model of fulminant hepatic failure in the rat. J Surg Res 2013;181:85-90. [PMID: 22748600 DOI: 10.1016/j.jss.2012.05.080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
88 García-Lastra R, San-Miguel B, Crespo I, Jorquera F, Alvarez M, González-Gallego J, Tuñón MJ. Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure. Vet Res 2010;41:2. [PMID: 19726019 DOI: 10.1051/vetres/2009050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
89 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 178] [Cited by in F6Publishing: 145] [Article Influence: 29.7] [Reference Citation Analysis]
90 Ong SY, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng. 2006;12:3477-3485. [PMID: 17518684 DOI: 10.1089/ten.2006.12.3477] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
91 Link TW, Arifin DR, Long CM, Walczak P, Muja N, Arepally A, Bulte JW. Use of Magnetocapsules for In Vivo Visualization and Enhanced Survival of Xenogeneic HepG2 Cell Transplants. Cell Med 2012;4:77-84. [PMID: 23293747 DOI: 10.3727/215517912X653337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
92 Bakos Á, Rikker C, Tóvárosi S, Kárteszi †. The therapeutical efficiency of the newest extracorporal elimination procedure (Prometheus® treatment) in acute liver failure caused by intoxication. Orvosi Hetilap 2007;148:1981-8. [DOI: 10.1556/oh.2007.28171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
93 Ekser B, Echeverri GJ, Hassett AC, Yazer MH, Long C, Meyer M, Ezzelarab M, Lin CC, Hara H, van der Windt DJ, Dons EM, Phelps C, Ayares D, Cooper DK, Gridelli B. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation. 2010;90:483-493. [PMID: 20606605 DOI: 10.1097/tp.0b013e3181e98d51] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
94 Sangan CB, Tosh D. Hepatic progenitor cells. Cell Tissue Res. 2010;342:131-137. [PMID: 20957497 DOI: 10.1007/s00441-010-1055-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
95 Chamuleau RA. Future of bioartificial liver support. World J Gastrointest Surg 2009;1:21-5. [PMID: 21160791 DOI: 10.4240/wjgs.v1.i1.21] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
96 Rozga J. Liver support technology--an update. Xenotransplantation. 2006;13:380-389. [PMID: 16925661 DOI: 10.1111/j.1399-3089.2006.00323.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
97 AlAhmari LS, AlShenaifi JY, AlAnazi RA, Abdo AA. Autologous bone marrow-derived cells in the treatment of liver disease patients. Saudi J Gastroenterol. 2015;21:5-10. [PMID: 25672232 DOI: 10.4103/1319-3767.151211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
98 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 Mazza G, Al-Akkad W, Rombouts K, Pinzani M. Liver tissue engineering: From implantable tissue to whole organ engineering. Hepatol Commun. 2018;2:131-141. [PMID: 29404520 DOI: 10.1002/hep4.1136] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 12.5] [Reference Citation Analysis]
100 Harm S, Strobl K, Hartmann J, Falkenhagen D. Alginate-Encapsulated Human Hepatoma C3A Cells for use in a Bioartificial Liver Device - The Hybrid-Mds. Int J Artif Organs 2009;32:769-78. [DOI: 10.1177/039139880903201102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
101 Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Gion T, Tanaka S, Shirabe K, Shimada M, Maehara Y. The newly established human hepatocyte cell line: application for the bioartificial liver. J Hepatol. 2005;42:557-564. [PMID: 15763342 DOI: 10.1016/j.jhep.2004.11.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
102 Yang HR, Thorat A, Jeng LB, Hsu SC, Li PC, Yeh CC, Chen TH, Poon KS. Living Donor Liver Transplantation in Acute Liver Failure Patients with Grade IV Encephalopathy: Is Deep Hepatic Coma Still an Absolute Contraindication? Ann Transplant. 2018;23:176-181. [PMID: 29531210 DOI: 10.12659/aot.907274] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
103 He YT, Qi YN, Zhang BQ, Li JB, Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol. 2019;25:3634-3648. [PMID: 31367162 DOI: 10.3748/wjg.v25.i27.3634] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
104 Buzhor E, Leshansky L, Blumenthal J, Barash H, Warshawsky D, Mazor Y, Shtrichman R. Cell-based therapy approaches: the hope for incurable diseases. Regen Med. 2014;9:649-672. [PMID: 25372080 DOI: 10.2217/rme.14.35] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 12.7] [Reference Citation Analysis]